After a conversation about a new chemotherapy drug, many patients and families are handed a cost estimate at the billing desk. If the word 'non-covered' (비급여, non-reimbursed) appears on it, the amount to prepare can change by an entire order of magnitude, even though the infusion itself looks the same.
The first thing worth separating: regulatory approval and insurance coverage are two different decisions. Approval means a drug may be used in a defined group of patients. Coverage means a public insurer has additionally judged the evidence and the value for money and agreed to pay part of the price. Because of that gap, the same drug can be covered for one cancer type or one line of therapy and non-covered outside those conditions. Between full coverage and no coverage there are also intermediate categories in which the patient pays a higher percentage. Using a drug outside its approved indication (off-label use) usually requires a separate institutional review, and the outcome affects what you pay.
This is where a common surprise appears. Cost-relief schemes for cancer patients reduce the patient's share of items the public insurer already recognizes. Items the insurer does not pay for at all sit outside that calculation. Annual out-of-pocket ceiling programs work the same way: they add up the covered portion and leave non-covered charges out. That is why a bill can look nothing like the low percentage a family expected.
Ways to reduce the burden do exist — patient assistance programs run by manufacturers, drug-cost support funds run by patient organizations or charitable foundations, and arrangements in which part of the price is refunded afterwards. Eligibility rules and application desks differ for each. One caution: because these supports reduce what you actually paid, they can interact with private indemnity health insurance, which typically reimburses genuine out-of-pocket expense. Amounts already covered elsewhere may be subtracted. Since this depends on your policy wording, enrollment date, and the insurer's own assessment, confirm it in writing before you proceed.
A practical order helps. Ask in the consultation room whether this drug is covered for your specific situation, and if not, the expected cost per cycle and how many cycles are planned. Ask the billing office or the hospital social work team whether you qualify for any assistance program and where the forms come from. Keep every document in one envelope from the start: itemized bills, receipts, detailed statements of charges, prescription and administration records, and any record of support money received. Note the amount for each cycle on one line; when a later bill differs, you will know what to ask about.
Finally, raising the subject of money is not a sign of giving up. How long a plan is financially sustainable is real information for treatment planning, and your team may be able to look at alternatives with you.
This article is general information and does not replace individual diagnosis or treatment. Coverage rules and support programs change over time and apply differently to each person, so please discuss your own decisions with your treating clinicians and your hospital's counseling or billing staff.